|
ACACA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.741500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.664030E-01 |
| Normal-vs-Stage2 |
7.156400E-04 |
| Normal-vs-Stage3 |
4.289400E-01 |
| Normal-vs-Stage4 |
6.373200E-01 |
| Stage1-vs-Stage2 |
1.060550E-03 |
| Stage1-vs-Stage3 |
7.772800E-01 |
| Stage1-vs-Stage4 |
6.347800E-01 |
| Stage2-vs-Stage3 |
5.315800E-03 |
| Stage2-vs-Stage4 |
5.497800E-03 |
| Stage3-vs-Stage4 |
8.364600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.028000E-01 |
| Normal-vs-AfricanAmerican |
2.247500E-02 |
| Normal-vs-Asian |
4.090400E-01 |
| Caucasian-vs-AfricanAmerican |
2.280600E-01 |
| Caucasian-vs-Asian |
9.196600E-01 |
| AfricanAmerican-vs-Asian |
3.334200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.878500E-02 |
| Normal-vs-Female |
8.145800E-02 |
| Male-vs-Female |
7.919400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.476000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.080600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.003100E-03 |
| Normal-vs-Age(81-100Yrs) |
6.038400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.099600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.659900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.956400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.240430E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.835200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.632810E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.317900E-03 |
| Classical-VS-Follicular |
5.220400E-03 |
| Classical-VS-Other |
2.106200E-01 |
| Classical-VS-Normal |
1.169970E-01 |
| Tall-VS-Follicular |
3.61749999999716E-05 |
| Tall-VS-Other |
8.563400E-01 |
| Tall-VS-Normal |
1.136790E-01 |
| Follicular-VS-Other |
4.317000E-03 |
| Follicular-VS-Normal |
3.765100E-04 |
| Other-VS-Normal |
2.176600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.120280E-02 |
| Normal-vs-N1 |
7.618600E-01 |
| N0-vs-N1 |
4.424400E-02 |
|
|
